Tag Archives: Trials

A 100% effective cancer vaccine? Russia’s Enteromix achieves success in trials; Here’s the full report you need to read

A 100% effective cancer vaccine? Russia’s Enteromix achieves success in trials; Here’s the full report you need to read

A vaccine that could change the way we fight cancer is making headlines. Russia’s Enteromix has reportedly achieved 100% efficacy in preclinical trials, showing both safety and strong tumour-fighting abilities, according to a report by Tass. Veronika Skvortsova, head of the Federal Medical and Biological Agency (FMBA), revealed the results at the Eastern Economic Forum (EEF). “The research spanned several …

Read More »

Enteromix, Russia’s cancer vaccine achieves 100% efficacy in clinical trials

Enteromix, Russia’s cancer vaccine achieves 100% efficacy in clinical trials

In what could be a miracle improving and saving thousands of lives across the globe, Russia’s mRNA-based vaccine Enteromix has displayed 100% efficacy and safety in clinical trials.The treatment which targets and destroys cancer cells while efficiently shrinking large tumours, now awaits final approval from the Ministry of Health before being made available to the public, RT India reported.Enteromix was …

Read More »

First-Ever Treatment for Rare Eye Disease Wins FDA Approval After Landmark Trials

First-Ever Treatment for Rare Eye Disease Wins FDA Approval After Landmark Trials

A novel implant has shown it can slow vision loss in macular telangiectasia type 2, offering the first approved treatment for this rare disorder. Credit: Stock Phase 3 clinical trial results from Scripps Research and its collaborators supported FDA approval of ENCELTO, the first cell-based treatment for the neurodegenerative retinal disease known as MacTel. For individuals with macular telangiectasia type …

Read More »

Pea Plant Virus Creates a Powerful Immune Attack on Cancer—A Cheap Treatment Headed for Clinical Trials

Pea Plant Virus Creates a Powerful Immune Attack on Cancer—A Cheap Treatment Headed for Clinical Trials

Immunotherapy vaccine attacks cancer cells A virus that infects the humble black-eyed pea plant is showing great promise as a low-cost, potent cancer immunotherapy—thanks to researchers at the University of California San Diego. The team led by chemical and nano engineers just published their study in Cell Biomaterials, showing how the cowpea mosaic virus (CPMV), unlike other plant viruses, is …

Read More »

Indian trials debunk sweet myths

Indian trials debunk sweet myths

Soutik Biswas BBC News, London Mansi Thapliyal There are over 1,000 varieties of mango grown in India As summer sweeps across India, one of the most common questions a leading Mumbai-based diabetologist hears from his patients is: “Can I eat mangoes?” “Mangoes, with their rich sweetness and diverse varieties, are a staple of Indian summers, and it’s understandable why people …

Read More »

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease  

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease  

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III trials to demonstrate statistically significant reduction in disease activity for Sjögren’s disease1  Ianalumab has the potential to become the first and only targeted treatment approved for patients with Sjögren’s disease Ianalumab was well tolerated and demonstrated a favorable safety profile in Sjögren’s …

Read More »

Lilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity – Eli Lilly and Company

Lilly’s oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity  Eli Lilly and Company Eli Lilly’s obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval  CNBC Lilly’s Obesity Pill Cut Body Weight by 11% in Key …

Read More »

Elon Musk’s Neuralink Launches “Mind Control” Chip Trials in UK: Paralyzed Patients Become Human Guinea Pigs in This Shocking Experiment

Elon Musk’s Neuralink Launches “Mind Control” Chip Trials in UK: Paralyzed Patients Become Human Guinea Pigs in This Shocking Experiment

IN A NUTSHELL 🧠 Neuralink has launched its first European clinical trial in the United Kingdom, focusing on individuals with severe paralysis. 🔍 The trial will involve implanting the N1 chip in seven patients to enable control of digital devices through thought. 💡 Neuralink’s technology uses 128 ultra-thin threads to connect approximately 1,000 electrodes to the brain. 🌍 The trial …

Read More »